Whenever new products for downstream-processing are available there is the question whether they are truly superior to previously used materials. acib offers to independently evaluate all kind of (prototype) chromatography matters and to address all questions regarding real-life applicability.
Whenever new products for downstream-processing are available there is the question whether they are truly superior to previously used materials. acib offers to independently evaluate all kind of (prototype) chromatography matters and to address all questions regarding real-life applicability.
You have a complex chemical process that is no longer competitive? Countries with low salary levels are beginning to gain market share for cost reasons? Let acib solve your problems by discovering new and cost-efficient routes for chemo-enzymatic synthesis of your target compound(s).
acib has a leading experience in industrial bioprocess design for enzymatic glycosylation reactions and is actively looking for new company collaborations interested in our glycosylation know-how.
acib developed a biotechnological based technology for the recycling of waste pharmaceutical blisters. Aluminium and plastic can be recovered by applying the concept of green chemistry.
Wastewater-based detection of emerging diseases has been proven to be a powerful tool during the COVID-19 pandemic. Now it’s high time to switch from a time-consuming manual and decentralized process to a fully-automated multiple-disease detection and surveillance system.
Yeast has been both a great model organism, as well as an efficient host for protein and metabolite production. Did you know that acib has made it even better.
Have you ever heard of the anaerobic fungal phylum Neocallimastigomycota? If not, you are probably not the only one, since research on this peculiar group is relatively young and cultivation was so far highly frustrating if at all possible … Thanks to recent breakthroughs these fungi and their enzymes can now be used for biotechnological applications!
Vaccines and gene therapy vectors are in high de‐ mand leading to challenging timelines for delivering sufficient amounts in highest quality. acib has both, the facilities and the expertise to provide you with fast and efficient production processes
acib has developed easy-to-use synthetic biology tools for the cost-efficient i) incorporation of non- natural amino acids, ii) assembly of multi-part DNA- constructs or iii) markerless gene integration/editing!